Completed
Brentuximab Vedotin Prevention of (GVHD) After Unrelated Allogeneic Stem Cell Transplantation
NCT01700751
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +14 more
- Locations
-
- Washington University School of Medicine St Louis, Missouri, United States